Drug Manufacturers - General · New Brunswick, NJ
Delayed quote: Sep 11, 2026, 4:00 PM EDT
Drug Manufacturers - General · New Brunswick, NJ
Delayed quote: Sep 11, 2026, 4:00 PM EDT
Over the latest trailing 12-month period, total return cagr is +52.17%. The comparable SPY value is +17.49%. Year-to-date total return is +30.40%. Total return includes price appreciation and reinvested dividends.
Growth of $10,000 in JNJ
$224,294
(22.4x return)
Invested on Sep 10, 1996
Growth of $10,000 in SPY (S&P 500)
$184,873
(18.5x return)
Invested on Sep 10, 1996
This chart illustrates the cumulative performance of a hypothetical $10,000 investment. It assumes that all dividends paid by both the stock and SPY are reinvested in additional shares on the payment date, showing the true long-term compounding impact of distributions.
YTD Total Return
+30.4%
1-Year Total Return
+52.1%
Current Dividend Yield
1.99%
Compound Annual Growth Rate (CAGR) is shown below. The difference between price CAGR and total return CAGR is the compound contribution of dividends reinvested.
| Holding Period | Price CAGR | Total Return CAGR | Dividend Addition |
|---|---|---|---|
| 1 Year | +48.8% | +52.2% | +3.4% |
| 3 Years | +17.8% | +21.1% | +3.4% |
| 5 Years | +9.7% | +12.8% | +3.1% |
| 10 Years | +8.4% | +11.4% | +3.0% |
| 15 Years | +10.0% | +13.1% | +3.2% |
| 20 Years |
| +7.4% |
| +10.5% |
| +3.1% |